CoinScoopEnveda Biosciences Secures $311 Million for AI-Driven Drug Discovery
Enveda Biosciences has raised $311 million to advance its nature-derived AI drug candidates into clinical trials. This funding is expected to accelerate the development of AI-driven pharmaceuticals and potentially impact global healthcare innovation.
Summaries are written by AI from the original article. Not investment advice.